• SENSEX 82,104.79
    512.34 (+0.63%)
  • BANKNIFTY 61,575.90
    541.80 (+0.89%)
  • NSE
    2,074.00 2,074.00(%)
  • Kaynes Tech
    2,780.00 2,780.00(%)
  • SBI
    1,099.70 1,234.80(%)
  • Lenskart Solut.
    745.90 767.40(%)
  • HDFC Bank
    817.80 1,017.90(%)
  • M & M
    3,360.00 3,840.00(%)
  • Millworks Technologies
    691.20 628.90(%)
  • Kalyan Jewellers
    729.00 729.00(%)
  • Cholaman.Inv.&Fn
    1,829.90 1,299.80(%)
  • Knowledge Realty
    111.84 129.49(%)
  • Persistent Systems
    5,943.15 4,242.65(%)
  • ICICI Bank
    1,577.05 1,187.55(%)
  • Jio Platforms
    1,433.70 1,490.00(%)
  • Sai Life
    1,785.65 786.15(%)
  • Cupid
    360.30 60.62(%)
  • Eicher Motors
    7,521.00 6,439.45(%)
  • Kotak Mah. Bank
    497.90 497.90(%)
  • Belrise Industri
    242.15 268.00(%)
  • Hitachi Energy
    30,665.00 16,104.00(%)
  • LIC Housing Fin.
    608.40 608.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Auro Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4899.0
  • ISIN : INE292C01011
235.10 1 (0.34%)
  • As on 16 Nov 2026 (EOD)
  • Today’s Low

    230.05
  • Today’s High

    243.00
  • Open

    238.00
  • Perv Close

    234.30
  • 52W Low

    199.95
  • 52W High

    317.00

Key Indicators

  • P/E(TTM)

    27.99

  • Mar.Cap (₹Cr.)

    146.53

  • Div & Yield %

    0.00

  • Book Value(₹)

    77.92

  • Debt-Equity Ratio

    0.34

  • AGM Date

    16-Nov-2026

  • EPS

    8.40

  • P/E Ratio

    27.99

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    146.53

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.23

  • BV (₹)

    77.90

  • Sales( ₹ in Cr.)

    30.74

  • NP (in Cr.)

    3.79

  • NP Var(%)

    106.0

  • Div%

    0.0

  • CPS (₹)

    10.60

  • EPS (₹)

    6.10

  • Traded Value (₹ in Lakhs)

    146.53

  • 52 Week High

    317.00

  • 52 Week Low

    199.95

  • Price BSE

    235.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    146.53

  • P/C Ratio

    22.20

  • P/E Ratio

    38.70

  • Price Vs.BV

    6.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 30.74 19.12 53.64 52.89 50.87 54.25
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 30.74 19.12 53.64 52.89 50.87 54.25
Other Income 2.01 0.93 1.50 0.94 1.09 0.76
Stock Adjustments 8.23 -4.13 2.48 1.61 0.98 -0.91
Total Income 40.98 15.92 57.62 55.44 52.94 54.10
EXPENDITURE :            
Raw Materials 14.29 5.08 29.04 37.30 33.76 27.64
Power and Fuel Cost 1.85 0.33 2.43 2.08 1.67 1.60
Employee Cost 5.86 2.47 3.91 3.76 3.70 3.64
Other Manufacturing Expenses 0.42 0.10 0.56 1.42 1.76 2.10
Selling and Administration Expenses 5.44 2.89 7.91 4.73 5.86 5.84
Miscellaneous Expenses 1.25 1.01 1.60 0.82 0.48 1.29
Employee Benefit Expenses 5.86 2.47 3.91 3.76 3.70 3.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 29.11 11.87 45.45 50.11 47.22 42.10
Operating Profit 11.87 4.06 12.18 5.33 5.72 12.00
Interest 4.25 1.08 0.74 0.81 0.83 0.46
Gross Profit 7.62 2.98 11.44 4.52 4.89 11.54
Depreciation 2.81 1.10 1.09 1.07 1.02 1.04
Profit Before Tax 4.81 1.88 10.35 3.45 3.87 10.50
Current Tax 0.00 0.10 2.74 1.00 1.07 3.20
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.28 -0.06 -0.19 0.00 -0.04 0.12
Reported Net Profit 3.53 1.84 7.79 2.44 2.84 7.18
Extraordinary Items -0.26 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.79 1.84 7.79 2.44 2.84 7.18
Adjustment below Net Profit 0.00 -0.95 -0.03 0.24 0.09 -0.09
P & L Balance brought forward 35.95 35.06 27.30 24.62 21.68 14.60
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 39.48 35.95 35.06 27.30 24.62 21.68
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.67 2.95 12.50 3.92 4.56 11.52
Earnings Per Share(Adj)-Unit Curr 5.67 2.95 12.50 3.92 4.56 11.52
Book Value 74.36 68.94 67.32 54.87 50.58 45.86
Book Value(Adj)-Unit Curr 74.36 68.94 67.32 54.87 50.58 45.86

Shareholding Pattern

  • Promoter Group

    52.41%

  • Public Share Holding

    47.60%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,183,013 18.98 1,183,013 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,083,126 33.42 2,083,126 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,266,139 52.41 3,266,139 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 400 0.01 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 400 0.01 0 1
2] Non Institution
Bodies Corporate 67,063 1.08 54,563 25
Clearing Members 7,673 0.12 7,673 6
Directors of their Relatives 10 0.00 10 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 386,751 6.21 242,051 225
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 53,275 0.85 52,775 71
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 404,744 6.49 404,744 7
Individuals holding nominal share capital up to Rs. 1 lakh 1,885,283 30.25 1,360,515 7,929
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 157,206 2.52 157,206 5
Sub Total 2,965,961 47.59 2,283,493 8,273
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,232,500 100.00 5,549,632 8,280

Company Background

Auro Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Auro Laboratories Ltd
  • BSE Code : 4899.0
  • ISIN : INE292C01011
  • Incorporation Year

    1989

  • Registered Office

    K-56 MIDC Indl Area
    Tarapur Boisar, Thane,
    Maharashtra-401506

  • Telephone

    91-22-66635456

  • FAX

  • Chairman

    Sharat Deorah

  • Managing Director

    Sharat Deorah

  • Company Secretary

    Padma Tapariya

  • Auditor

    B L Dasharda & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Auro Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Auro Labs. 235.10 32.75 30.74 28.50 9.16
Abbott India 25,953.25 7,217.19 6,929.05 33.37 43.78
Astrazeneca Phar 6,032.75 2,304.07 2,275.58 84.86 27.86
Glaxosmi. Pharma 2,649.00 3,932.76 3,790.20 39.36 58.17
Evonile Pharma 1,499.80 393.10 354.33 -1,315.61 15.94
Cipla 1,394.00 20,102.60 18,979.95 42.49 13.88
Bliss GVS Pharma 661.95 773.53 729.81 43.15 12.51
Amrutanjan Healt 507.00 520.13 502.55 25.58 24.16
Fermenta Biotec. 469.85 474.15 450.25 22.20 18.77
Guj. Themis Bio. 359.70 168.25 165.82 109.00 18.05
Ambalal Sarabhai 38.59 19.52 3.94 65.41 6.77